These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 25501681)

  • 1. Antigenic differences between AS03 adjuvanted influenza A (H1N1) pandemic vaccines: implications for pandemrix-associated narcolepsy risk.
    Vaarala O; Vuorela A; Partinen M; Baumann M; Freitag TL; Meri S; Saavalainen P; Jauhiainen M; Soliymani R; Kirjavainen T; Olsen P; Saarenpää-Heikkilä O; Rouvinen J; Roivainen M; Nohynek H; Jokinen J; Julkunen I; Kilpi T
    PLoS One; 2014; 9(12):e114361. PubMed ID: 25501681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies against ganglioside GM3 are associated with narcolepsy-cataplexy developing after Pandemrix vaccination against 2009 pandemic H1N1 type influenza virus.
    Saariaho AH; Vuorela A; Freitag TL; Pizza F; Plazzi G; Partinen M; Vaarala O; Meri S
    J Autoimmun; 2015 Sep; 63():68-75. PubMed ID: 26227560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A/H1N1 antibodies and TRIB2 autoantibodies in narcolepsy patients diagnosed in conjunction with the Pandemrix vaccination campaign in Sweden 2009-2010.
    Lind A; Ramelius A; Olsson T; Arnheim-Dahlström L; Lamb F; Khademi M; Ambati A; Maeurer M; Nilsson AL; Bomfim IL; Fink K; Lernmark Å
    J Autoimmun; 2014 May; 50():99-106. PubMed ID: 24485154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Pandemrix and Arepanrix, two pH1N1 AS03-adjuvanted vaccines differentially associated with narcolepsy development.
    Jacob L; Leib R; Ollila HM; Bonvalet M; Adams CM; Mignot E
    Brain Behav Immun; 2015 Jul; 47():44-57. PubMed ID: 25452148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody Affinity Against 2009 A/H1N1 Influenza and Pandemrix Vaccine Nucleoproteins Differs Between Childhood Narcolepsy Patients and Controls.
    Lind A; Freyhult E; Ramelius A; Olsson T; Arnheim-Dahlström L; Lamb F; Khademi M; Ambati A; Maeurer M; Lima Bomfim I; Fink K; Fex M; Törn C; Elding Larsson H; Lernmark Å
    Viral Immunol; 2017 Oct; 30(8):590-600. PubMed ID: 28796576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No serological evidence of influenza A H1N1pdm09 virus infection as a contributing factor in childhood narcolepsy after Pandemrix vaccination campaign in Finland.
    Melén K; Partinen M; Tynell J; Sillanpää M; Himanen SL; Saarenpää-Heikkilä O; Hublin C; Olsen P; Ilonen J; Nohynek H; Syrjänen R; Kilpi T; Vuorela A; Kirjavainen T; Vaarala O; Julkunen I
    PLoS One; 2013; 8(8):e68402. PubMed ID: 23950869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2.
    Ahmed SS; Volkmuth W; Duca J; Corti L; Pallaoro M; Pezzicoli A; Karle A; Rigat F; Rappuoli R; Narasimhan V; Julkunen I; Vuorela A; Vaarala O; Nohynek H; Pasini FL; Montomoli E; Trombetta C; Adams CM; Rothbard J; Steinman L
    Sci Transl Med; 2015 Jul; 7(294):294ra105. PubMed ID: 26136476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Narcolepsy Associated with Pandemrix Vaccine.
    Sarkanen T; Alakuijala A; Julkunen I; Partinen M
    Curr Neurol Neurosci Rep; 2018 Jun; 18(7):43. PubMed ID: 29855798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A coordinated cross-disciplinary research initiative to address an increased incidence of narcolepsy following the 2009-2010 Pandemrix vaccination programme in Sweden.
    Feltelius N; Persson I; Ahlqvist-Rastad J; Andersson M; Arnheim-Dahlström L; Bergman P; Granath F; Adori C; Hökfelt T; Kühlmann-Berenzon S; Liljeström P; Maeurer M; Olsson T; Örtqvist Å; Partinen M; Salmonson T; Zethelius B
    J Intern Med; 2015 Oct; 278(4):335-53. PubMed ID: 26123389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Narcolepsy with cataplexy: an autoimmune disease?].
    Jacob L; Dauvilliers Y
    Med Sci (Paris); 2014 Dec; 30(12):1136-43. PubMed ID: 25537044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced influenza A H1N1 T cell epitope recognition and cross-reactivity to protein-O-mannosyltransferase 1 in Pandemrix-associated narcolepsy type 1.
    Vuorela A; Freitag TL; Leskinen K; Pessa H; Härkönen T; Stracenski I; Kirjavainen T; Olsen P; Saarenpää-Heikkilä O; Ilonen J; Knip M; Vaheri A; Partinen M; Saavalainen P; Meri S; Vaarala O
    Nat Commun; 2021 Apr; 12(1):2283. PubMed ID: 33863907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: what is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants.
    Ahmed SS; Schur PH; MacDonald NE; Steinman L
    J Autoimmun; 2014 May; 50():1-11. PubMed ID: 24559657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Narcolepsy and adjuvanted pandemic influenza A (H1N1) 2009 vaccines - Multi-country assessment.
    Weibel D; Sturkenboom M; Black S; de Ridder M; Dodd C; Bonhoeffer J; Vanrolleghem A; van der Maas N; Lammers GJ; Overeem S; Gentile A; Giglio N; Castellano V; Kwong JC; Murray BJ; Cauch-Dudek K; Juhasz D; Campitelli M; Datta AN; Kallweit U; Huang WT; Huang YS; Hsu CY; Chen HC; Giner-Soriano M; Morros R; Gaig C; Tió E; Perez-Vilar S; Diez-Domingo J; Puertas FJ; Svenson LW; Mahmud SM; Carleton B; Naus M; Arnheim-Dahlström L; Pedersen L; DeStefano F; Shimabukuro TT
    Vaccine; 2018 Oct; 36(41):6202-6211. PubMed ID: 30122647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Narcolepsy and Pandemic Influenza Vaccination: What We Need to Know to be Ready for the Next Pandemic.
    Edwards K; Lambert PH; Black S
    Pediatr Infect Dis J; 2019 Aug; 38(8):873-876. PubMed ID: 31306400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long term effectiveness of adjuvanted influenza A(H1N1)pdm09 vaccine in children.
    Örtqvist Å; Bennet R; Hamrin J; Rinder MR; Lindblad H; Öhd JN; Eriksson M
    Vaccine; 2015 May; 33(22):2558-61. PubMed ID: 25869891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of Narcolepsy after AS03 Adjuvanted Pandemic A/H1N1 2009 Influenza Vaccine in Adults: A Case-Coverage Study in England.
    Stowe J; Andrews N; Kosky C; Dennis G; Eriksson S; Hall A; Leschziner G; Reading P; Shneerson JM; Donegan K; Miller E
    Sleep; 2016 May; 39(5):1051-7. PubMed ID: 26856903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Change in risk for narcolepsy over time and impact of definition of onset date following vaccination with AS03 adjuvanted pandemic A/H1N1 influenza vaccine (Pandemrix) during the 2009 H1N1 influenza pandemic.
    Granath F; Gedeborg R; Smedje H; Feltelius N
    Pharmacoepidemiol Drug Saf; 2019 Aug; 28(8):1045-1053. PubMed ID: 31062443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meeting report narcolepsy and pandemic influenza vaccination: What we know and what we need to know before the next pandemic? A report from the 2nd IABS meeting.
    Edwards K; Hanquet G; Black S; Mignot E; Jankosky C; Shimabukuro T; Miller E; Nohynek H; Neels P
    Biologicals; 2019 Jul; 60():1-7. PubMed ID: 31130313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France.
    Dauvilliers Y; Arnulf I; Lecendreux M; Monaca Charley C; Franco P; Drouot X; d'Ortho MP; Launois S; Lignot S; Bourgin P; Nogues B; Rey M; Bayard S; Scholz S; Lavault S; Tubert-Bitter P; Saussier C; Pariente A;
    Brain; 2013 Aug; 136(Pt 8):2486-96. PubMed ID: 23884811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis.
    Miller E; Andrews N; Stellitano L; Stowe J; Winstone AM; Shneerson J; Verity C
    BMJ; 2013 Feb; 346():f794. PubMed ID: 23444425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.